SYRS: Syros Pharmaceuticals, Inc Quarterly EPS earnings growth

Brandmark of Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals (SYRS) aims to automate drug discovery through AI-driven DNA analysis. The quarterly earnings per share (EPS) growth, as shown on the GURU.Markets chart which recorded 0.00 as the current metric, illustrates the path toward this goal. However, the geneticists' ambitions to manage gene expression face workforce reductions and a high cash burn rate following unsuccessful tests.

Syros Pharmaceuticals, Inc. (SYRS) - Quarterly EPS earnings growth from 07/04/2022 to 03/29/2025

Analytical breakdowns and data insights for company Syros Pharmaceuticals (SYRS)

Initial company analysis:Syros Pharmaceuticals, Inc - SYRS
Manufactured product of Syros Pharmaceuticals, Inc

For Syros Pharmaceuticals (SYRS), which develops precision therapies for resistant forms of leukemia, earnings per share dynamics reflect the efficiency of R&D capital expenditures and commercial potential within oncology centers. By analyzing the current quarterly EPS growth rate, investors assess the pace of business scaling, smoothing out seasonal reporting fluctuations to identify a sustainable development trend for the company within the gene expression control niche.

Main competitors

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics)|Quarterly EPS earnings growth nautilus.bio NAUT|Metagenomi Inc. - Quarterly EPS earnings growth|DTIL (Precision BioSciences Inc.) - Year-over-year earnings per share growth for the last 12 months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Imunon (IMNN)|Quarterly EPS earnings growth PHIO|Mustang Bio - Year-over-year earnings per share growth for the last 12 months|TransCode Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Bionano Genomics, Inc. (BNGO)|APDN - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Year-over-year earnings per share growth for the last twelve months|OMGA: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Singular Genomics Systems, Inc.|Quarterly EPS earnings growth Regulus Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)